Company
Virica Biotech
Virica is a cell enhancer company dedicated to improving manufacturing productivity and reducing costs, increasing access to cell and gene therapies by uniquely addressing the challenge of cellular defenses.
Also known as Virica Biotech Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Founded
- 2018
- Customers
- Cell & gene therapy and vaccine manufacturers
- Legal name
- Virica Biotech Inc.
- viricabiotech.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are a hyper-growth biotechnology company enabling viral medicines that improve the lives of people. We own proprietary small molecules called Viral Sensitizers (VSE™) that target the natural antiviral defenses of cells to boost virus manufacturing yields (e.g., vaccines) and improve the effectiveness of therapeutics that rely on viral vectors (e.g., gene therapy).
Funding snapshot
- Total raised
- $7.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $60K2024-04-29
Funding rounds
- Round, 2024
- $60K2024-04-29, SEC form D sold, 2 investors
- Round, 2024
- $3M2024-01-22, SEC form D sold, 2 investors
- Round, 2022
- $500K2022-04-25, SEC form D sold, 1 investor
- Round, 2021
- $3.5M2021-09-27, SEC form D sold, 1 investor
Products
- Other
- Viral Sensitizers (VSE™)
Loading relationship preview